Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3533)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2022 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mohamed GA, Nashaat EH, Fawzy HM, ElGhandour AM. Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma. World J Hepatol 2022; 14(3): 623-633 [PMID: 35582295 DOI: 10.4254/wjh.v14.i3.623] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i3/623.htm |
| Number | Citing Articles |
| 1 |
Marcela Botelho de Carvalho, Gabriel Machado Chavez Passos Jorge, Luiza Wolf Zanardo, Leticia Miho Hamada, Larissa dos Santos Izabel, Sergio Santoro, Juliana Magdalon. The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials. American Journal of Physiology-Endocrinology and Metabolism 2024; 327(3): E279 doi: 10.1152/ajpendo.00156.2024
|